High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey

BACKGROUND: Patients with schizophrenia have an increased prevalence of metabolic disturbances compared with the general population. However, the mechanisms underlying the metabolic side effects of antipsychotics are unknown. The aim of the present study was to compare the levels of high-density lip...

Descripción completa

Detalles Bibliográficos
Autores principales: Ono, Shin, Sugai, Takuro, Suzuki, Yutaro, Yamazaki, Manabu, Shimoda, Kazutaka, Mori, Takao, Ozeki, Yuji, Matsuda, Hiroshi, Sugawara, Norio, Yasui-Furukori, Norio, Okamoto, Kurefu, Sagae, Toyoaki, Someya, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992846/
https://www.ncbi.nlm.nih.gov/pubmed/29879941
http://dx.doi.org/10.1186/s12888-018-1764-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992846/
https://www.ncbi.nlm.nih.gov/pubmed/29879941
http://dx.doi.org/10.1186/s12888-018-1764-1

Ejemplares similares